Pancreatic Cancer Risk Inversely Linked with Statin Use

Share this content:
Statin use is inversely associated with pancreatic cancer risk, with evidence of a sex-specific risk reduction.
Statin use is inversely associated with pancreatic cancer risk, with evidence of a sex-specific risk reduction.

Statin use is inversely associated with pancreatic cancer risk, with evidence of a sex-specific risk reduction, according to a study published in Cancer.

Evan J. Walker, from the University of California in San Francisco, and colleagues examined the correlation between statin use and the risk of pancreatic cancer.

The authors recruited 536 patients with confirmed diagnoses of pancreatic cancer, who were frequency-matched by sex and age with 869 controls over a six-year period (2006 to 2011).

An epidemiological risk factor questionnaire was administered that covered topics such as medical history, lifestyle factors, and medication usage.

The researchers observed a 34 percent reduction in pancreatic cancer risk in association with ever use of statins (odds ratio [OR], 0.66; 95 percent confidence interval [CI], 0.47 to 0.92).

Risk was statistically significantly reduced in men only in sex-stratified analyses (OR for men, 0.50; 95 percent CI, 0.32 to 0.79; OR for women, 0.86; 95 percent CI, 0.52 to 1.43).

RELATED: Masitinib May Be Effective Treatment in Pancreatic Cancer Subgroups

There was an association between duration of use and pancreatic cancer risk (>10-year use: overall OR, 0.51; OR for men, 0.41; 95 percent CI, 0.21 to 0.80).

"This is the largest case-control study to demonstrate an inverse association between statin use and pancreatic cancer risk," the authors write.

"Further research is warranted to better characterize this association and clarify the roles of underlying biologic mechanisms."

Reference

  1. Walker, Evan J., ScB, et al. "Statin use and risk of pancreatic cancer: Results from a large, clinic-based case-control study." Cancer. DOI: 10.1002/cncr.29256. [epub ahead of print]. February 3, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters